These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 27262235

  • 1. Tamoxifen-induced cytotoxicity in breast cancer cells is mediated by glucose-regulated protein 78 (GRP78) via AKT (Thr308) regulation.
    Pujari R, Jose J, Bhavnani V, Kumar N, Shastry P, Pal JK.
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):57-67. PubMed ID: 27262235
    [Abstract] [Full Text] [Related]

  • 2. Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals.
    Yan SC, Liu YP, Zhang LY, Qu JL, Xu L, Liu J, Zhang Y, Hou KZ, Teng YE, Qu XJ.
    Acta Oncol; 2011 Jun; 50(5):693-9. PubMed ID: 21175263
    [Abstract] [Full Text] [Related]

  • 3. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.
    Ying L, Zhu Z, Xu Z, He T, Li E, Guo Z, Liu F, Jiang C, Wang Q.
    PLoS One; 2015 Jun; 10(6):e0129593. PubMed ID: 26115510
    [Abstract] [Full Text] [Related]

  • 4. [Effect of Evn-50 on cell growth and apoptosis in tamoxifen-resistance human breast cancer cell line MCF-7/TAM-R].
    Hu HY, Zhou J, Wan F, Dong LF, Zhang F, Wang YK, Chen FF, Chen YD.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):498-505. PubMed ID: 23086641
    [Abstract] [Full Text] [Related]

  • 5. Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer.
    Rajput S, Kumar BN, Sarkar S, Das S, Azab B, Santhekadur PK, Das SK, Emdad L, Sarkar D, Fisher PB, Mandal M.
    PLoS One; 2013 Sep; 8(4):e61342. PubMed ID: 23613836
    [Abstract] [Full Text] [Related]

  • 6. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
    Li Z, Wang N, Fang J, Huang J, Tian F, Li C, Xie F.
    Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
    [Abstract] [Full Text] [Related]

  • 7. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
    Gu W, Dong N, Wang P, Shi C, Yang J, Wang J.
    Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
    [Abstract] [Full Text] [Related]

  • 8. Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.
    Kawiak A, Domachowska A, Jaworska A, Lojkowska E.
    Sci Rep; 2017 Mar 13; 7():43781. PubMed ID: 28287102
    [Abstract] [Full Text] [Related]

  • 9. CHM-1 Suppresses Formation of Cell Surface-associated GRP78-p85α Complexes, Inhibiting PI3K-AKT Signaling and Inducing Apoptosis of Human Nasopharyngeal Carcinoma Cells.
    Lin ML, Chen SS, Ng SH.
    Anticancer Res; 2015 Oct 13; 35(10):5359-68. PubMed ID: 26408697
    [Abstract] [Full Text] [Related]

  • 10. GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells.
    Liu L, Liu S, Luo H, Chen C, Zhang X, He L, Tu G.
    Aging (Albany NY); 2021 Jun 28; 13(12):16178-16197. PubMed ID: 34182538
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.
    Zheng A, Kallio A, Härkönen P.
    Endocrinology; 2007 Jun 28; 148(6):2764-77. PubMed ID: 17363451
    [Abstract] [Full Text] [Related]

  • 12. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
    Gao C, Yuan X, Jiang Z, Gan D, Ding L, Sun Y, Zhou J, Xu L, Liu Y, Wang G.
    Breast Cancer Res Treat; 2019 Jul 28; 176(2):291-301. PubMed ID: 31006103
    [Abstract] [Full Text] [Related]

  • 13. Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells.
    Jordan NJ, Gee JM, Barrow D, Wakeling AE, Nicholson RI.
    Breast Cancer Res Treat; 2004 Sep 28; 87(2):167-80. PubMed ID: 15377841
    [Abstract] [Full Text] [Related]

  • 14. Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells.
    Lin Y, Wang Z, Liu L, Chen L.
    Lung Cancer; 2011 Mar 28; 71(3):291-7. PubMed ID: 20599289
    [Abstract] [Full Text] [Related]

  • 15. Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.
    Kim J, Lee J, Kim C, Choi J, Kim A.
    Tumour Biol; 2016 May 28; 37(5):5811-9. PubMed ID: 26581908
    [Abstract] [Full Text] [Related]

  • 16. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
    Zhong T, Xu F, Xu J, Liu L, Chen Y.
    Biomed Pharmacother; 2015 Feb 28; 69():317-25. PubMed ID: 25661377
    [Abstract] [Full Text] [Related]

  • 17. Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells.
    Mao Z, Zhou J, Luan J, Sheng W, Shen X, Dong X.
    Biomed Pharmacother; 2014 Mar 28; 68(2):179-83. PubMed ID: 24184201
    [Abstract] [Full Text] [Related]

  • 18. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
    Phuong NT, Kim SK, Lim SC, Kim HS, Kim TH, Lee KY, Ahn SG, Yoon JH, Kang KW.
    Breast Cancer Res Treat; 2011 Nov 28; 130(1):73-83. PubMed ID: 21170675
    [Abstract] [Full Text] [Related]

  • 19. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M, Yang J, Lv W, Wang S, Du T, Zhang K, Wu Y, Feng X.
    Biosci Rep; 2022 Jan 28; 42(1):. PubMed ID: 34935899
    [Abstract] [Full Text] [Related]

  • 20. Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.
    Zhang L, Ren X, Cheng Y, Huber-Keener K, Liu X, Zhang Y, Yuan YS, Yang JW, Liu CG, Yang JM.
    Biochem Pharmacol; 2013 Sep 15; 86(6):726-33. PubMed ID: 23856293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.